Suppressor of cytokine signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex

Molecular Endocrinology

Volumn 20, Issue 7, 2006, Pages 1587-1596

  Frobøse, Helle ^a   Rønn, Sif Groth ^a   Heding, Peter E ^a   Mendoza, Heidi ^b   Cohen, Philip ^b   Mandrup Poulsen, Thomas ^a,c   Billestrup, Nils ^a  

^a STENO DIABETES CENTER   (Denmark)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MYELOID DIFFERENTIATION FACTOR 88; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL CELL; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RAT; SIGNAL TRANSDUCTION; UBIQUITINATION;

CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE DOSAGE; HUMANS; INTERLEUKIN-1; MAP KINASE KINASE KINASES; MULTIPROTEIN COMPLEXES; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; PROTEIN BINDING; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TNF RECEPTOR-ASSOCIATED FACTOR 6; UBIQUITIN;

EID: 33745194935     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2005-0301     Document Type: Article

References (37)

1. Dinarello CA 1997 Interleukin-1. Cytokine Growth Factor Rev 8:253-265
2. O'Neill LA, Greene C 1998 Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 63:650-657
3. Auron PE 1998 The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine Growth Factor Rev 9:221-237
4. Burns K, Clatworthy J, Martin L, Martinon F, Plumpton C, Maschera B, Lewis A, Ray K, Tschopp J, Volpe F 2000 Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat Cell Biol 2:346-351
5. Jiang Z, Ninomiya-Tsuji J, Qian Y, Matsumoto K, Li X 2002 Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol Cell Biol 22:7158-7167
6. Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H, Irie K, Ninomiya-Tsuji J, Matsumoto K 2000 TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell 5:649-658
7. Wang C, Deng L, Hong M, Akkaraju GR, Inoue JI, Chen ZJ 2001 TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412:346-351
8. Janeway CA, Travers P, Walport M, Capra JD 1999 Immunobiology: the immune system in health and disease. 4th ed. New York: Garland
9. Andersen NA, Larsen CM, Mandrup-Poulsen T 2000 TNFα and IFNγ potentiate IL-1β induced mitogen activated protein kinase activity in rat pancreatic islets of Langerhans. Diabetologia 43:1389-1396
10. Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, Van Obberghen E 2000 SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem 275:15985-15991
11. Krebs DL, Hilton DJ 2000 SOCS: physiological suppressors of cytokine signaling. J Cell Sci 113(Part 16):2813-2819
12. Nicholson SE, Hilton DJ 1998 The SOCS proteins: a new family of negative regulators of signal transduction. J Leukoc Biol 63:665-668
13. Nicholson SE, Willson TA, Farley A, Starr R, Zhang JG, Baca M, Alexander WS, Metcalf D, Hilton DJ, Nicola NA 1999 Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J 18:375-385
14. Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Hara T, Miyajima A 1995 A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J 14:2816-2826
15. Krebs DL, Hilton DJ 2001 SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19:378-387
16. Karlsen AE, Ronn SG, Lindberg K, Johannesen J, Galsgaard ED, Pociot F, Nielsen JH, Mandrup-Poulsen T, Nerup J, Billestrup N 2001 Suppressor of cytokine signaling 3 (SOCS-3) protects β-cells against interleukin-1β- and interferon-γ-mediated toxicity. Proc Natl Acad Sci USA 98:12191-12196
17. Karlsen AE, Heding PE, Frobose H, Ronn SG, Kruhoffer M, Orntoft TF, Darville M, Eizirik DL, Pociot F, Nerup J, Mandrup-Poulsen T, Billestrup N 2004 Suppressor of cytokine signalling (SOCS)-3 protects β cells against IL-1β-mediated toxicity through inhibition of multiple nuclear factor-κB-regulated proapoptotic pathways. Diabetologia 47:1998-2011
18. Cheung PCF, Campbell DG, Nebreda AR, Cohen P 2003 Feedback control of the protein kinase TAK1 by SAPK2a/p38 α. EMBO J 22:5793-5805
19. Cheung PCF, Nebreda AR, Cohen P 2004 TAB3, a new binding partner of the protein kinase TAK1. Biochem J 378:27-34
20. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ 1997 A family of cytokine-inducible inhibitors of signalling. Nature 387:917-921
21. Pociot F, Karlsen A, Mandrup-Poulsen T 2001 Type 1 diabetes. In: Bertagna X, Fischer J, Groop L, Schoemaker J, Serio M, Wass J, eds. Endocrinology and metabolism. New York: McGraw-Hill; 593-606
22. Kinjyo I, Hanada T, Inagaki-Ohara K, Mori H, Aki D, Ohishi M, Yoshida H, Kubo M, Yoshimura A 2002 SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17:583-591
23. Nakagawa R, Naka T, Tsutsui H, Fujimoto M, Kimura A, Abe T, Seki E, Sato S, Takeuchi O, Takeda K, Akira S, Yamanishi K, Kawase I, Nakanishi K, Kishimoto T 2002 SOCS-1 participates in negative regulation of LPS responses. Immunity 17:677-687
24. Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G, Rottapel R, Yamaoka S, Lu KP 2003 Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 12:1413-1426
25. Akira S, Takeda K 2004 Toll-like receptor signalling. Nat Rev Immunol 4:499-511
26. Baetz A, Frey M, Heeg K, Dalpke AH 2004 Suppressor of cytokine signaling (SOCS) proteins indirectly regulate Toll-like receptor signaling in innate immune cells. J Biol Chem 279:54708-54715
27. Qian Y, Commane M, Ninomiya-Tsuji J, Matsumoto K, Li X 2001 IRAK-mediated translocation of TRAF6 and TAB2 in the interleukin-1-induced activation of NFκB. J Biol Chem 276:41661-41667
28. Takaesu G, Ninomiya-Tsuji J, Kishida S, Li X, Stark GR, Matsumoto K 2001 Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway. Mol Cell Biol 21:2475-2484
29. Nicholson SE, De Souza D, Fabri LJ, Corbin J, Willson TA, Zhang JG, Silva A, Asimakis M, Farley A, Nash AD, Metcalf D, Hilton DJ, Nicola NA, Baca M 2000 Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc Natl Acad Sci USA 97:6493-6498
30. Hansen JA, Lindberg K, Hilton DJ, Nielsen JH, Billestrup N 1999 Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins. Mol Endocrinol 13:1832-1843
31. Sasaki A, Yasukawa H, Shouda T, Kitamura T, Dikic I, Yoshimura A 2000 CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J Biol Chem 275:29338-29347
32. Sasaki A, Yasukawa H, Suzuki A, Kamizono S, Syoda T, Kinjyo I, Sasaki M, Johnston JA, Yoshimura A 1999 Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 4:339-351
33. Kile BT, Schulman BA, Alexander WS, Nicola NA, Martin HM, Hilton DJ 2002 The SOCS box: a tale of destruction and degradation. Trends Biochem Sci 27:235-241
34. Kamura T, Sato S, Haque D, Liu L, Kaelin Jr WG, Conaway RC, Conaway JW 1998 The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev 12:3872-3881
35. Kamura T, Burian D, Yan Q, Schmidt SL, Lane WS, Querido E, Branton PE, Shilatifard A, Conaway RC, Conaway JW 2001 Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase. J Biol Chem 276:29748-29753
36. Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, Simpson RJ, Moritz RL, Cary D, Richardson R, Hausmann G, Kile BJ, Kent SB, Alexander WS, Metcalf D, Hilton DJ, Nicola NA, Baca M 1999 The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci USA 96:2071-2076
37. Rønn SG, Hansen JA, Lindberg K, Karlsen AE, Billestrup N 2002 The effect of suppressor of cytokine signaling 3 on GH signaling in β-cells. Mol Endocrinol 16:2124-2134